nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—OPRD1—coronary artery disease	0.333	1	CbGaD
Oxycodone—CYP3A7—Eplerenone—coronary artery disease	0.0269	0.0638	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0269	0.0638	CbGbCtD
Oxycodone—CYP3A5—Clopidogrel—coronary artery disease	0.0217	0.0515	CbGbCtD
Oxycodone—CYP3A5—Eplerenone—coronary artery disease	0.0202	0.0478	CbGbCtD
Oxycodone—CYP3A7—Simvastatin—coronary artery disease	0.0173	0.0411	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0173	0.0411	CbGbCtD
Oxycodone—CYP3A7—Lovastatin—coronary artery disease	0.017	0.0402	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.017	0.0402	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0155	0.0366	CbGbCtD
Oxycodone—CYP3A7—Atorvastatin—coronary artery disease	0.0155	0.0366	CbGbCtD
Oxycodone—CYP3A5—Rosuvastatin—coronary artery disease	0.014	0.0332	CbGbCtD
Oxycodone—CYP3A4—Ticagrelor—coronary artery disease	0.0137	0.0325	CbGbCtD
Oxycodone—CYP3A5—Simvastatin—coronary artery disease	0.013	0.0308	CbGbCtD
Oxycodone—CYP3A5—Lovastatin—coronary artery disease	0.0127	0.0302	CbGbCtD
Oxycodone—CYP3A5—Pravastatin—coronary artery disease	0.0127	0.0302	CbGbCtD
Oxycodone—CYP3A4—Fenofibrate—coronary artery disease	0.0122	0.029	CbGbCtD
Oxycodone—CYP3A5—Atorvastatin—coronary artery disease	0.0116	0.0275	CbGbCtD
Oxycodone—CYP3A5—Losartan—coronary artery disease	0.0106	0.0251	CbGbCtD
Oxycodone—CYP2D6—Niacin—coronary artery disease	0.0101	0.0239	CbGbCtD
Oxycodone—CYP3A4—Gemfibrozil—coronary artery disease	0.00977	0.0231	CbGbCtD
Oxycodone—CYP2D6—Timolol—coronary artery disease	0.00939	0.0222	CbGbCtD
Oxycodone—CYP3A4—Clopidogrel—coronary artery disease	0.00847	0.0201	CbGbCtD
Oxycodone—CYP2D6—Captopril—coronary artery disease	0.00826	0.0196	CbGbCtD
Oxycodone—CYP2D6—Simvastatin—coronary artery disease	0.00798	0.0189	CbGbCtD
Oxycodone—CYP3A4—Eplerenone—coronary artery disease	0.00788	0.0187	CbGbCtD
Oxycodone—CYP2D6—Pravastatin—coronary artery disease	0.00781	0.0185	CbGbCtD
Oxycodone—CYP2D6—Lovastatin—coronary artery disease	0.00781	0.0185	CbGbCtD
Oxycodone—CYP2D6—Atorvastatin—coronary artery disease	0.00711	0.0169	CbGbCtD
Oxycodone—CYP3A4—Enalapril—coronary artery disease	0.00702	0.0166	CbGbCtD
Oxycodone—CYP3A4—Ezetimibe—coronary artery disease	0.00546	0.0129	CbGbCtD
Oxycodone—CYP3A4—Rosuvastatin—coronary artery disease	0.00546	0.0129	CbGbCtD
Oxycodone—CYP3A4—Simvastatin—coronary artery disease	0.00507	0.012	CbGbCtD
Oxycodone—CYP3A4—Pravastatin—coronary artery disease	0.00497	0.0118	CbGbCtD
Oxycodone—CYP3A4—Lovastatin—coronary artery disease	0.00497	0.0118	CbGbCtD
Oxycodone—CYP3A4—Atorvastatin—coronary artery disease	0.00452	0.0107	CbGbCtD
Oxycodone—CYP3A4—Losartan—coronary artery disease	0.00414	0.0098	CbGbCtD
Oxycodone—Naloxone—CREB1—coronary artery disease	0.000799	0.215	CrCbGaD
Oxycodone—Nalbuphine—OPRD1—coronary artery disease	0.000524	0.141	CrCbGaD
Oxycodone—Naltrexone—OPRD1—coronary artery disease	0.000427	0.115	CrCbGaD
Oxycodone—Oxymorphone—OPRD1—coronary artery disease	0.000427	0.115	CrCbGaD
Oxycodone—Hydrocodone—OPRD1—coronary artery disease	0.000374	0.1	CrCbGaD
Oxycodone—Codeine—OPRD1—coronary artery disease	0.000325	0.0874	CrCbGaD
Oxycodone—Naloxone—OPRD1—coronary artery disease	0.000312	0.0838	CrCbGaD
Oxycodone—Hydromorphone—OPRD1—coronary artery disease	0.00031	0.0832	CrCbGaD
Oxycodone—Naloxone—ESR1—coronary artery disease	0.000155	0.0417	CrCbGaD
Oxycodone—Naloxone—ALB—coronary artery disease	6.91e-05	0.0186	CrCbGaD
Oxycodone—Fatigue—Losartan—coronary artery disease	4.22e-05	0.000238	CcSEcCtD
Oxycodone—Headache—Ezetimibe—coronary artery disease	4.21e-05	0.000238	CcSEcCtD
Oxycodone—Malaise—Lisinopril—coronary artery disease	4.21e-05	0.000237	CcSEcCtD
Oxycodone—Anaphylactic shock—Ramipril—coronary artery disease	4.2e-05	0.000237	CcSEcCtD
Oxycodone—Oedema—Ramipril—coronary artery disease	4.2e-05	0.000237	CcSEcCtD
Oxycodone—Vertigo—Lisinopril—coronary artery disease	4.19e-05	0.000237	CcSEcCtD
Oxycodone—Dry mouth—Timolol—coronary artery disease	4.19e-05	0.000236	CcSEcCtD
Oxycodone—Pain—Losartan—coronary artery disease	4.19e-05	0.000236	CcSEcCtD
Oxycodone—Constipation—Losartan—coronary artery disease	4.19e-05	0.000236	CcSEcCtD
Oxycodone—Syncope—Lisinopril—coronary artery disease	4.18e-05	0.000236	CcSEcCtD
Oxycodone—Vomiting—Eplerenone—coronary artery disease	4.18e-05	0.000236	CcSEcCtD
Oxycodone—Feeling abnormal—Furosemide—coronary artery disease	4.18e-05	0.000236	CcSEcCtD
Oxycodone—Leukopenia—Lisinopril—coronary artery disease	4.18e-05	0.000236	CcSEcCtD
Oxycodone—Nausea—Fenofibrate—coronary artery disease	4.17e-05	0.000235	CcSEcCtD
Oxycodone—Pruritus—Niacin—coronary artery disease	4.16e-05	0.000235	CcSEcCtD
Oxycodone—Asthenia—Pravastatin—coronary artery disease	4.16e-05	0.000235	CcSEcCtD
Oxycodone—Gastrointestinal pain—Furosemide—coronary artery disease	4.15e-05	0.000234	CcSEcCtD
Oxycodone—Rash—Eplerenone—coronary artery disease	4.15e-05	0.000234	CcSEcCtD
Oxycodone—Urticaria—Perindopril—coronary artery disease	4.15e-05	0.000234	CcSEcCtD
Oxycodone—Hypersensitivity—Trandolapril—coronary artery disease	4.15e-05	0.000234	CcSEcCtD
Oxycodone—Dermatitis—Eplerenone—coronary artery disease	4.14e-05	0.000234	CcSEcCtD
Oxycodone—Diarrhoea—Valsartan—coronary artery disease	4.14e-05	0.000234	CcSEcCtD
Oxycodone—Confusional state—Timolol—coronary artery disease	4.14e-05	0.000234	CcSEcCtD
Oxycodone—Shock—Ramipril—coronary artery disease	4.13e-05	0.000233	CcSEcCtD
Oxycodone—Hypersensitivity—Enalapril—coronary artery disease	4.13e-05	0.000233	CcSEcCtD
Oxycodone—Abdominal pain—Perindopril—coronary artery disease	4.13e-05	0.000233	CcSEcCtD
Oxycodone—Body temperature increased—Perindopril—coronary artery disease	4.13e-05	0.000233	CcSEcCtD
Oxycodone—Palpitations—Lisinopril—coronary artery disease	4.12e-05	0.000233	CcSEcCtD
Oxycodone—Diarrhoea—Olmesartan—coronary artery disease	4.12e-05	0.000233	CcSEcCtD
Oxycodone—Headache—Eplerenone—coronary artery disease	4.12e-05	0.000233	CcSEcCtD
Oxycodone—Nervous system disorder—Ramipril—coronary artery disease	4.12e-05	0.000232	CcSEcCtD
Oxycodone—Anaphylactic shock—Timolol—coronary artery disease	4.1e-05	0.000232	CcSEcCtD
Oxycodone—Oedema—Timolol—coronary artery disease	4.1e-05	0.000232	CcSEcCtD
Oxycodone—Pruritus—Pravastatin—coronary artery disease	4.1e-05	0.000231	CcSEcCtD
Oxycodone—Loss of consciousness—Lisinopril—coronary artery disease	4.1e-05	0.000231	CcSEcCtD
Oxycodone—Nausea—Clopidogrel—coronary artery disease	4.1e-05	0.000231	CcSEcCtD
Oxycodone—Tachycardia—Ramipril—coronary artery disease	4.1e-05	0.000231	CcSEcCtD
Oxycodone—Skin disorder—Ramipril—coronary artery disease	4.08e-05	0.00023	CcSEcCtD
Oxycodone—Infection—Timolol—coronary artery disease	4.08e-05	0.00023	CcSEcCtD
Oxycodone—Vomiting—Simvastatin—coronary artery disease	4.08e-05	0.00023	CcSEcCtD
Oxycodone—Hypersensitivity—Telmisartan—coronary artery disease	4.07e-05	0.00023	CcSEcCtD
Oxycodone—Cough—Lisinopril—coronary artery disease	4.07e-05	0.00023	CcSEcCtD
Oxycodone—Nausea—Lovastatin—coronary artery disease	4.07e-05	0.00023	CcSEcCtD
Oxycodone—Hyperhidrosis—Ramipril—coronary artery disease	4.06e-05	0.000229	CcSEcCtD
Oxycodone—Rash—Simvastatin—coronary artery disease	4.04e-05	0.000228	CcSEcCtD
Oxycodone—Dermatitis—Simvastatin—coronary artery disease	4.04e-05	0.000228	CcSEcCtD
Oxycodone—Asthenia—Trandolapril—coronary artery disease	4.04e-05	0.000228	CcSEcCtD
Oxycodone—Shock—Timolol—coronary artery disease	4.04e-05	0.000228	CcSEcCtD
Oxycodone—Feeling abnormal—Losartan—coronary artery disease	4.03e-05	0.000228	CcSEcCtD
Oxycodone—Urticaria—Furosemide—coronary artery disease	4.03e-05	0.000228	CcSEcCtD
Oxycodone—Diarrhoea—Niacin—coronary artery disease	4.03e-05	0.000227	CcSEcCtD
Oxycodone—Nervous system disorder—Timolol—coronary artery disease	4.02e-05	0.000227	CcSEcCtD
Oxycodone—Asthenia—Enalapril—coronary artery disease	4.02e-05	0.000227	CcSEcCtD
Oxycodone—Headache—Simvastatin—coronary artery disease	4.02e-05	0.000227	CcSEcCtD
Oxycodone—Abdominal pain—Furosemide—coronary artery disease	4.01e-05	0.000226	CcSEcCtD
Oxycodone—Body temperature increased—Furosemide—coronary artery disease	4.01e-05	0.000226	CcSEcCtD
Oxycodone—Gastrointestinal pain—Losartan—coronary artery disease	4e-05	0.000226	CcSEcCtD
Oxycodone—Dizziness—Valsartan—coronary artery disease	4e-05	0.000226	CcSEcCtD
Oxycodone—Anorexia—Ramipril—coronary artery disease	4e-05	0.000226	CcSEcCtD
Oxycodone—Nausea—Ezetimibe—coronary artery disease	3.99e-05	0.000225	CcSEcCtD
Oxycodone—Skin disorder—Timolol—coronary artery disease	3.99e-05	0.000225	CcSEcCtD
Oxycodone—Dizziness—Olmesartan—coronary artery disease	3.98e-05	0.000225	CcSEcCtD
Oxycodone—Pruritus—Trandolapril—coronary artery disease	3.98e-05	0.000225	CcSEcCtD
Oxycodone—Myalgia—Lisinopril—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Arthralgia—Lisinopril—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Chest pain—Lisinopril—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Hyperhidrosis—Timolol—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Asthenia—Telmisartan—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Pruritus—Enalapril—coronary artery disease	3.97e-05	0.000224	CcSEcCtD
Oxycodone—Diarrhoea—Pravastatin—coronary artery disease	3.96e-05	0.000224	CcSEcCtD
Oxycodone—Anxiety—Lisinopril—coronary artery disease	3.96e-05	0.000223	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.94e-05	0.000223	CcSEcCtD
Oxycodone—Discomfort—Lisinopril—coronary artery disease	3.92e-05	0.000221	CcSEcCtD
Oxycodone—Hypotension—Ramipril—coronary artery disease	3.92e-05	0.000221	CcSEcCtD
Oxycodone—Anorexia—Timolol—coronary artery disease	3.91e-05	0.000221	CcSEcCtD
Oxycodone—Pruritus—Telmisartan—coronary artery disease	3.91e-05	0.000221	CcSEcCtD
Oxycodone—Nausea—Eplerenone—coronary artery disease	3.91e-05	0.000221	CcSEcCtD
Oxycodone—Dizziness—Niacin—coronary artery disease	3.89e-05	0.00022	CcSEcCtD
Oxycodone—Urticaria—Losartan—coronary artery disease	3.89e-05	0.00022	CcSEcCtD
Oxycodone—Dry mouth—Lisinopril—coronary artery disease	3.88e-05	0.000219	CcSEcCtD
Oxycodone—Abdominal pain—Losartan—coronary artery disease	3.87e-05	0.000218	CcSEcCtD
Oxycodone—Body temperature increased—Losartan—coronary artery disease	3.87e-05	0.000218	CcSEcCtD
Oxycodone—Asthenia—Captopril—coronary artery disease	3.86e-05	0.000218	CcSEcCtD
Oxycodone—Diarrhoea—Trandolapril—coronary artery disease	3.85e-05	0.000217	CcSEcCtD
Oxycodone—Vomiting—Valsartan—coronary artery disease	3.85e-05	0.000217	CcSEcCtD
Oxycodone—Confusional state—Lisinopril—coronary artery disease	3.84e-05	0.000217	CcSEcCtD
Oxycodone—Diarrhoea—Enalapril—coronary artery disease	3.83e-05	0.000216	CcSEcCtD
Oxycodone—Hypotension—Timolol—coronary artery disease	3.83e-05	0.000216	CcSEcCtD
Oxycodone—Dizziness—Pravastatin—coronary artery disease	3.83e-05	0.000216	CcSEcCtD
Oxycodone—Vomiting—Olmesartan—coronary artery disease	3.83e-05	0.000216	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.82e-05	0.000216	CcSEcCtD
Oxycodone—Rash—Valsartan—coronary artery disease	3.82e-05	0.000215	CcSEcCtD
Oxycodone—Dermatitis—Valsartan—coronary artery disease	3.81e-05	0.000215	CcSEcCtD
Oxycodone—Nausea—Simvastatin—coronary artery disease	3.81e-05	0.000215	CcSEcCtD
Oxycodone—Anaphylactic shock—Lisinopril—coronary artery disease	3.81e-05	0.000215	CcSEcCtD
Oxycodone—Oedema—Lisinopril—coronary artery disease	3.81e-05	0.000215	CcSEcCtD
Oxycodone—Pruritus—Captopril—coronary artery disease	3.8e-05	0.000215	CcSEcCtD
Oxycodone—Rash—Olmesartan—coronary artery disease	3.8e-05	0.000214	CcSEcCtD
Oxycodone—Insomnia—Ramipril—coronary artery disease	3.8e-05	0.000214	CcSEcCtD
Oxycodone—Dermatitis—Olmesartan—coronary artery disease	3.79e-05	0.000214	CcSEcCtD
Oxycodone—Headache—Valsartan—coronary artery disease	3.79e-05	0.000214	CcSEcCtD
Oxycodone—Diarrhoea—Telmisartan—coronary artery disease	3.78e-05	0.000213	CcSEcCtD
Oxycodone—Infection—Lisinopril—coronary artery disease	3.78e-05	0.000213	CcSEcCtD
Oxycodone—Headache—Olmesartan—coronary artery disease	3.77e-05	0.000213	CcSEcCtD
Oxycodone—Paraesthesia—Ramipril—coronary artery disease	3.77e-05	0.000213	CcSEcCtD
Oxycodone—Shock—Lisinopril—coronary artery disease	3.75e-05	0.000211	CcSEcCtD
Oxycodone—Asthenia—Perindopril—coronary artery disease	3.74e-05	0.000211	CcSEcCtD
Oxycodone—Dyspnoea—Ramipril—coronary artery disease	3.74e-05	0.000211	CcSEcCtD
Oxycodone—Vomiting—Niacin—coronary artery disease	3.74e-05	0.000211	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Timolol—coronary artery disease	3.74e-05	0.000211	CcSEcCtD
Oxycodone—Hypersensitivity—Furosemide—coronary artery disease	3.74e-05	0.000211	CcSEcCtD
Oxycodone—Somnolence—Ramipril—coronary artery disease	3.73e-05	0.000211	CcSEcCtD
Oxycodone—Dizziness—Trandolapril—coronary artery disease	3.72e-05	0.00021	CcSEcCtD
Oxycodone—Tachycardia—Lisinopril—coronary artery disease	3.72e-05	0.00021	CcSEcCtD
Oxycodone—Insomnia—Timolol—coronary artery disease	3.71e-05	0.000209	CcSEcCtD
Oxycodone—Rash—Niacin—coronary artery disease	3.71e-05	0.000209	CcSEcCtD
Oxycodone—Dermatitis—Niacin—coronary artery disease	3.71e-05	0.000209	CcSEcCtD
Oxycodone—Dizziness—Enalapril—coronary artery disease	3.71e-05	0.000209	CcSEcCtD
Oxycodone—Skin disorder—Lisinopril—coronary artery disease	3.7e-05	0.000209	CcSEcCtD
Oxycodone—Dyspepsia—Ramipril—coronary artery disease	3.69e-05	0.000209	CcSEcCtD
Oxycodone—Pruritus—Perindopril—coronary artery disease	3.69e-05	0.000208	CcSEcCtD
Oxycodone—Headache—Niacin—coronary artery disease	3.69e-05	0.000208	CcSEcCtD
Oxycodone—Paraesthesia—Timolol—coronary artery disease	3.68e-05	0.000208	CcSEcCtD
Oxycodone—Vomiting—Pravastatin—coronary artery disease	3.68e-05	0.000208	CcSEcCtD
Oxycodone—Hyperhidrosis—Lisinopril—coronary artery disease	3.68e-05	0.000208	CcSEcCtD
Oxycodone—Diarrhoea—Captopril—coronary artery disease	3.68e-05	0.000208	CcSEcCtD
Oxycodone—Dyspnoea—Timolol—coronary artery disease	3.66e-05	0.000207	CcSEcCtD
Oxycodone—Dizziness—Telmisartan—coronary artery disease	3.66e-05	0.000206	CcSEcCtD
Oxycodone—Rash—Pravastatin—coronary artery disease	3.65e-05	0.000206	CcSEcCtD
Oxycodone—Dermatitis—Pravastatin—coronary artery disease	3.65e-05	0.000206	CcSEcCtD
Oxycodone—Decreased appetite—Ramipril—coronary artery disease	3.65e-05	0.000206	CcSEcCtD
Oxycodone—Somnolence—Timolol—coronary artery disease	3.65e-05	0.000206	CcSEcCtD
Oxycodone—Asthenia—Furosemide—coronary artery disease	3.64e-05	0.000205	CcSEcCtD
Oxycodone—Headache—Pravastatin—coronary artery disease	3.63e-05	0.000205	CcSEcCtD
Oxycodone—Anorexia—Lisinopril—coronary artery disease	3.63e-05	0.000205	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Ramipril—coronary artery disease	3.62e-05	0.000205	CcSEcCtD
Oxycodone—Fatigue—Ramipril—coronary artery disease	3.62e-05	0.000204	CcSEcCtD
Oxycodone—Dyspepsia—Timolol—coronary artery disease	3.61e-05	0.000204	CcSEcCtD
Oxycodone—Hypersensitivity—Losartan—coronary artery disease	3.61e-05	0.000204	CcSEcCtD
Oxycodone—Nausea—Valsartan—coronary artery disease	3.6e-05	0.000203	CcSEcCtD
Oxycodone—Pruritus—Furosemide—coronary artery disease	3.59e-05	0.000203	CcSEcCtD
Oxycodone—Constipation—Ramipril—coronary artery disease	3.59e-05	0.000203	CcSEcCtD
Oxycodone—Nausea—Olmesartan—coronary artery disease	3.58e-05	0.000202	CcSEcCtD
Oxycodone—Vomiting—Trandolapril—coronary artery disease	3.58e-05	0.000202	CcSEcCtD
Oxycodone—Diarrhoea—Perindopril—coronary artery disease	3.57e-05	0.000202	CcSEcCtD
Oxycodone—Decreased appetite—Timolol—coronary artery disease	3.57e-05	0.000201	CcSEcCtD
Oxycodone—Vomiting—Enalapril—coronary artery disease	3.56e-05	0.000201	CcSEcCtD
Oxycodone—Hypotension—Lisinopril—coronary artery disease	3.56e-05	0.000201	CcSEcCtD
Oxycodone—Dizziness—Captopril—coronary artery disease	3.55e-05	0.000201	CcSEcCtD
Oxycodone—Rash—Trandolapril—coronary artery disease	3.55e-05	0.0002	CcSEcCtD
Oxycodone—Dermatitis—Trandolapril—coronary artery disease	3.54e-05	0.0002	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Timolol—coronary artery disease	3.54e-05	0.0002	CcSEcCtD
Oxycodone—Fatigue—Timolol—coronary artery disease	3.54e-05	0.0002	CcSEcCtD
Oxycodone—Rash—Enalapril—coronary artery disease	3.53e-05	0.000199	CcSEcCtD
Oxycodone—Dermatitis—Enalapril—coronary artery disease	3.53e-05	0.000199	CcSEcCtD
Oxycodone—Headache—Trandolapril—coronary artery disease	3.53e-05	0.000199	CcSEcCtD
Oxycodone—Vomiting—Telmisartan—coronary artery disease	3.51e-05	0.000198	CcSEcCtD
Oxycodone—Asthenia—Losartan—coronary artery disease	3.51e-05	0.000198	CcSEcCtD
Oxycodone—Headache—Enalapril—coronary artery disease	3.51e-05	0.000198	CcSEcCtD
Oxycodone—Pain—Timolol—coronary artery disease	3.51e-05	0.000198	CcSEcCtD
Oxycodone—Nausea—Niacin—coronary artery disease	3.5e-05	0.000197	CcSEcCtD
Oxycodone—Rash—Telmisartan—coronary artery disease	3.49e-05	0.000197	CcSEcCtD
Oxycodone—Dermatitis—Telmisartan—coronary artery disease	3.48e-05	0.000197	CcSEcCtD
Oxycodone—Diarrhoea—Furosemide—coronary artery disease	3.47e-05	0.000196	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.47e-05	0.000196	CcSEcCtD
Oxycodone—Pruritus—Losartan—coronary artery disease	3.46e-05	0.000195	CcSEcCtD
Oxycodone—Headache—Telmisartan—coronary artery disease	3.46e-05	0.000195	CcSEcCtD
Oxycodone—Feeling abnormal—Ramipril—coronary artery disease	3.46e-05	0.000195	CcSEcCtD
Oxycodone—Dizziness—Perindopril—coronary artery disease	3.45e-05	0.000195	CcSEcCtD
Oxycodone—Insomnia—Lisinopril—coronary artery disease	3.44e-05	0.000194	CcSEcCtD
Oxycodone—Nausea—Pravastatin—coronary artery disease	3.44e-05	0.000194	CcSEcCtD
Oxycodone—Gastrointestinal pain—Ramipril—coronary artery disease	3.43e-05	0.000194	CcSEcCtD
Oxycodone—Paraesthesia—Lisinopril—coronary artery disease	3.42e-05	0.000193	CcSEcCtD
Oxycodone—Vomiting—Captopril—coronary artery disease	3.42e-05	0.000193	CcSEcCtD
Oxycodone—Dyspnoea—Lisinopril—coronary artery disease	3.39e-05	0.000192	CcSEcCtD
Oxycodone—Rash—Captopril—coronary artery disease	3.39e-05	0.000191	CcSEcCtD
Oxycodone—Dermatitis—Captopril—coronary artery disease	3.39e-05	0.000191	CcSEcCtD
Oxycodone—Somnolence—Lisinopril—coronary artery disease	3.38e-05	0.000191	CcSEcCtD
Oxycodone—Feeling abnormal—Timolol—coronary artery disease	3.38e-05	0.000191	CcSEcCtD
Oxycodone—Headache—Captopril—coronary artery disease	3.37e-05	0.00019	CcSEcCtD
Oxycodone—Gastrointestinal pain—Timolol—coronary artery disease	3.36e-05	0.000189	CcSEcCtD
Oxycodone—Dizziness—Furosemide—coronary artery disease	3.35e-05	0.000189	CcSEcCtD
Oxycodone—Dyspepsia—Lisinopril—coronary artery disease	3.35e-05	0.000189	CcSEcCtD
Oxycodone—Diarrhoea—Losartan—coronary artery disease	3.35e-05	0.000189	CcSEcCtD
Oxycodone—Nausea—Trandolapril—coronary artery disease	3.34e-05	0.000189	CcSEcCtD
Oxycodone—Urticaria—Ramipril—coronary artery disease	3.33e-05	0.000188	CcSEcCtD
Oxycodone—Nausea—Enalapril—coronary artery disease	3.33e-05	0.000188	CcSEcCtD
Oxycodone—Vomiting—Perindopril—coronary artery disease	3.32e-05	0.000187	CcSEcCtD
Oxycodone—Abdominal pain—Ramipril—coronary artery disease	3.32e-05	0.000187	CcSEcCtD
Oxycodone—Body temperature increased—Ramipril—coronary artery disease	3.32e-05	0.000187	CcSEcCtD
Oxycodone—Decreased appetite—Lisinopril—coronary artery disease	3.31e-05	0.000187	CcSEcCtD
Oxycodone—Rash—Perindopril—coronary artery disease	3.29e-05	0.000186	CcSEcCtD
Oxycodone—Dermatitis—Perindopril—coronary artery disease	3.29e-05	0.000186	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.29e-05	0.000186	CcSEcCtD
Oxycodone—Nausea—Telmisartan—coronary artery disease	3.28e-05	0.000185	CcSEcCtD
Oxycodone—Fatigue—Lisinopril—coronary artery disease	3.28e-05	0.000185	CcSEcCtD
Oxycodone—Headache—Perindopril—coronary artery disease	3.27e-05	0.000185	CcSEcCtD
Oxycodone—Urticaria—Timolol—coronary artery disease	3.26e-05	0.000184	CcSEcCtD
Oxycodone—Pain—Lisinopril—coronary artery disease	3.26e-05	0.000184	CcSEcCtD
Oxycodone—Constipation—Lisinopril—coronary artery disease	3.26e-05	0.000184	CcSEcCtD
Oxycodone—Body temperature increased—Timolol—coronary artery disease	3.24e-05	0.000183	CcSEcCtD
Oxycodone—Abdominal pain—Timolol—coronary artery disease	3.24e-05	0.000183	CcSEcCtD
Oxycodone—Dizziness—Losartan—coronary artery disease	3.24e-05	0.000183	CcSEcCtD
Oxycodone—Vomiting—Furosemide—coronary artery disease	3.23e-05	0.000182	CcSEcCtD
Oxycodone—Rash—Furosemide—coronary artery disease	3.2e-05	0.000181	CcSEcCtD
Oxycodone—Dermatitis—Furosemide—coronary artery disease	3.2e-05	0.00018	CcSEcCtD
Oxycodone—Nausea—Captopril—coronary artery disease	3.19e-05	0.00018	CcSEcCtD
Oxycodone—Headache—Furosemide—coronary artery disease	3.18e-05	0.000179	CcSEcCtD
Oxycodone—Feeling abnormal—Lisinopril—coronary artery disease	3.14e-05	0.000177	CcSEcCtD
Oxycodone—Gastrointestinal pain—Lisinopril—coronary artery disease	3.11e-05	0.000176	CcSEcCtD
Oxycodone—Vomiting—Losartan—coronary artery disease	3.11e-05	0.000176	CcSEcCtD
Oxycodone—Nausea—Perindopril—coronary artery disease	3.1e-05	0.000175	CcSEcCtD
Oxycodone—Hypersensitivity—Ramipril—coronary artery disease	3.09e-05	0.000175	CcSEcCtD
Oxycodone—Rash—Losartan—coronary artery disease	3.09e-05	0.000174	CcSEcCtD
Oxycodone—Dermatitis—Losartan—coronary artery disease	3.08e-05	0.000174	CcSEcCtD
Oxycodone—Headache—Losartan—coronary artery disease	3.07e-05	0.000173	CcSEcCtD
Oxycodone—Urticaria—Lisinopril—coronary artery disease	3.02e-05	0.000171	CcSEcCtD
Oxycodone—Hypersensitivity—Timolol—coronary artery disease	3.02e-05	0.000171	CcSEcCtD
Oxycodone—Nausea—Furosemide—coronary artery disease	3.01e-05	0.00017	CcSEcCtD
Oxycodone—Asthenia—Ramipril—coronary artery disease	3.01e-05	0.00017	CcSEcCtD
Oxycodone—Body temperature increased—Lisinopril—coronary artery disease	3.01e-05	0.00017	CcSEcCtD
Oxycodone—Abdominal pain—Lisinopril—coronary artery disease	3.01e-05	0.00017	CcSEcCtD
Oxycodone—Pruritus—Ramipril—coronary artery disease	2.97e-05	0.000168	CcSEcCtD
Oxycodone—Asthenia—Timolol—coronary artery disease	2.94e-05	0.000166	CcSEcCtD
Oxycodone—Nausea—Losartan—coronary artery disease	2.91e-05	0.000164	CcSEcCtD
Oxycodone—Pruritus—Timolol—coronary artery disease	2.9e-05	0.000164	CcSEcCtD
Oxycodone—Diarrhoea—Ramipril—coronary artery disease	2.87e-05	0.000162	CcSEcCtD
Oxycodone—Diarrhoea—Timolol—coronary artery disease	2.81e-05	0.000158	CcSEcCtD
Oxycodone—Hypersensitivity—Lisinopril—coronary artery disease	2.8e-05	0.000158	CcSEcCtD
Oxycodone—Dizziness—Ramipril—coronary artery disease	2.78e-05	0.000157	CcSEcCtD
Oxycodone—Asthenia—Lisinopril—coronary artery disease	2.73e-05	0.000154	CcSEcCtD
Oxycodone—Dizziness—Timolol—coronary artery disease	2.71e-05	0.000153	CcSEcCtD
Oxycodone—Pruritus—Lisinopril—coronary artery disease	2.69e-05	0.000152	CcSEcCtD
Oxycodone—Vomiting—Ramipril—coronary artery disease	2.67e-05	0.000151	CcSEcCtD
Oxycodone—Rash—Ramipril—coronary artery disease	2.65e-05	0.000149	CcSEcCtD
Oxycodone—Dermatitis—Ramipril—coronary artery disease	2.64e-05	0.000149	CcSEcCtD
Oxycodone—Headache—Ramipril—coronary artery disease	2.63e-05	0.000148	CcSEcCtD
Oxycodone—Vomiting—Timolol—coronary artery disease	2.61e-05	0.000147	CcSEcCtD
Oxycodone—Diarrhoea—Lisinopril—coronary artery disease	2.6e-05	0.000147	CcSEcCtD
Oxycodone—Rash—Timolol—coronary artery disease	2.59e-05	0.000146	CcSEcCtD
Oxycodone—Dermatitis—Timolol—coronary artery disease	2.58e-05	0.000146	CcSEcCtD
Oxycodone—Headache—Timolol—coronary artery disease	2.57e-05	0.000145	CcSEcCtD
Oxycodone—Dizziness—Lisinopril—coronary artery disease	2.52e-05	0.000142	CcSEcCtD
Oxycodone—Nausea—Ramipril—coronary artery disease	2.49e-05	0.000141	CcSEcCtD
Oxycodone—Nausea—Timolol—coronary artery disease	2.44e-05	0.000138	CcSEcCtD
Oxycodone—Vomiting—Lisinopril—coronary artery disease	2.42e-05	0.000137	CcSEcCtD
Oxycodone—Rash—Lisinopril—coronary artery disease	2.4e-05	0.000135	CcSEcCtD
Oxycodone—Dermatitis—Lisinopril—coronary artery disease	2.4e-05	0.000135	CcSEcCtD
Oxycodone—Headache—Lisinopril—coronary artery disease	2.38e-05	0.000135	CcSEcCtD
Oxycodone—Nausea—Lisinopril—coronary artery disease	2.26e-05	0.000128	CcSEcCtD
Oxycodone—CYP2D6—Metabolism—VCAN—coronary artery disease	5.18e-06	8.07e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6R—coronary artery disease	5.18e-06	8.06e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCA1—coronary artery disease	5.18e-06	8.06e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—coronary artery disease	5.17e-06	8.06e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	5.15e-06	8.02e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDOA—coronary artery disease	5.14e-06	8.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.14e-06	8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HK2—coronary artery disease	5.14e-06	8e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	5.13e-06	7.98e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FN1—coronary artery disease	5.11e-06	7.96e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—F2—coronary artery disease	5.11e-06	7.96e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—coronary artery disease	5.11e-06	7.95e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	5.09e-06	7.93e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	5.08e-06	7.91e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—coronary artery disease	5.06e-06	7.88e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	5.05e-06	7.86e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	5.03e-06	7.84e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GGT1—coronary artery disease	5.01e-06	7.81e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GOT1—coronary artery disease	5.01e-06	7.81e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—DCN—coronary artery disease	4.99e-06	7.77e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.93e-06	7.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	4.93e-06	7.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—C3—coronary artery disease	4.92e-06	7.66e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KIT—coronary artery disease	4.89e-06	7.61e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDH2—coronary artery disease	4.86e-06	7.56e-05	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.86e-06	7.56e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	4.85e-06	7.55e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LCAT—coronary artery disease	4.83e-06	7.53e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.83e-06	7.53e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AGT—coronary artery disease	4.81e-06	7.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA4—coronary artery disease	4.74e-06	7.39e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LIPC—coronary artery disease	4.73e-06	7.37e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HBA1—coronary artery disease	4.73e-06	7.37e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	4.73e-06	7.37e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2C19—coronary artery disease	4.73e-06	7.37e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—coronary artery disease	4.71e-06	7.33e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOC3—coronary artery disease	4.7e-06	7.32e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF2—coronary artery disease	4.7e-06	7.31e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	4.69e-06	7.31e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	4.69e-06	7.31e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LDLR—coronary artery disease	4.68e-06	7.28e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGT—coronary artery disease	4.67e-06	7.28e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOA1—coronary artery disease	4.66e-06	7.25e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—coronary artery disease	4.66e-06	7.25e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREB1—coronary artery disease	4.66e-06	7.25e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—coronary artery disease	4.63e-06	7.21e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	4.62e-06	7.19e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—coronary artery disease	4.62e-06	7.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.58e-06	7.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCLM—coronary artery disease	4.58e-06	7.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—coronary artery disease	4.58e-06	7.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—coronary artery disease	4.58e-06	7.13e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCLC—coronary artery disease	4.57e-06	7.11e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CETP—coronary artery disease	4.57e-06	7.11e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—coronary artery disease	4.56e-06	7.09e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6R—coronary artery disease	4.54e-06	7.07e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOA1—coronary artery disease	4.53e-06	7.05e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SDC1—coronary artery disease	4.52e-06	7.03e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—coronary artery disease	4.5e-06	7.01e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAK2—coronary artery disease	4.5e-06	7.01e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—coronary artery disease	4.49e-06	6.99e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—coronary artery disease	4.48e-06	6.97e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	4.46e-06	6.95e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	4.46e-06	6.94e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	4.46e-06	6.94e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—coronary artery disease	4.44e-06	6.92e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.44e-06	6.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.44e-06	6.91e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	4.41e-06	6.87e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAT—coronary artery disease	4.38e-06	6.82e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—coronary artery disease	4.37e-06	6.81e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.37e-06	6.81e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—F2—coronary artery disease	4.32e-06	6.72e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FN1—coronary artery disease	4.32e-06	6.72e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.31e-06	6.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HADH—coronary artery disease	4.31e-06	6.71e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	4.3e-06	6.7e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	4.27e-06	6.65e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.27e-06	6.64e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.27e-06	6.64e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.26e-06	6.63e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOB—coronary artery disease	4.25e-06	6.62e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	4.25e-06	6.62e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CTGF—coronary artery disease	4.17e-06	6.49e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—coronary artery disease	4.14e-06	6.44e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KIT—coronary artery disease	4.13e-06	6.44e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.13e-06	6.43e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GOT2—coronary artery disease	4.13e-06	6.43e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—coronary artery disease	4.12e-06	6.41e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	4.11e-06	6.39e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—coronary artery disease	4.1e-06	6.39e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.08e-06	6.36e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX2—coronary artery disease	4.08e-06	6.36e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA2—coronary artery disease	4.08e-06	6.36e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LPL—coronary artery disease	4.06e-06	6.33e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—coronary artery disease	4.06e-06	6.32e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—coronary artery disease	4.05e-06	6.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX4—coronary artery disease	4.03e-06	6.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HK1—coronary artery disease	4.03e-06	6.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.03e-06	6.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.03e-06	6.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HADHA—coronary artery disease	3.99e-06	6.21e-05	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	3.97e-06	6.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	3.97e-06	6.18e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—coronary artery disease	3.96e-06	6.17e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAK2—coronary artery disease	3.95e-06	6.14e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.94e-06	6.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—coronary artery disease	3.93e-06	6.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREB1—coronary artery disease	3.93e-06	6.13e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—coronary artery disease	3.93e-06	6.12e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—coronary artery disease	3.91e-06	6.08e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPA—coronary artery disease	3.9e-06	6.07e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	3.87e-06	6.02e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CD36—coronary artery disease	3.86e-06	6.01e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—coronary artery disease	3.85e-06	5.99e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6R—coronary artery disease	3.84e-06	5.98e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—coronary artery disease	3.83e-06	5.96e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.81e-06	5.93e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.8e-06	5.91e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—coronary artery disease	3.78e-06	5.89e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.77e-06	5.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.77e-06	5.86e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA5—coronary artery disease	3.74e-06	5.82e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—coronary artery disease	3.72e-06	5.78e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—coronary artery disease	3.69e-06	5.74e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.68e-06	5.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—P4HB—coronary artery disease	3.66e-06	5.7e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.66e-06	5.7e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	3.6e-06	5.61e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	3.6e-06	5.61e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.6e-06	5.6e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.6e-06	5.6e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.59e-06	5.6e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GGT1—coronary artery disease	3.57e-06	5.55e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GOT1—coronary artery disease	3.57e-06	5.55e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—coronary artery disease	3.53e-06	5.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—coronary artery disease	3.48e-06	5.42e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	3.48e-06	5.42e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AGT—coronary artery disease	3.48e-06	5.41e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—coronary artery disease	3.45e-06	5.37e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—coronary artery disease	3.43e-06	5.34e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—coronary artery disease	3.42e-06	5.33e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—coronary artery disease	3.41e-06	5.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—VCAN—coronary artery disease	3.39e-06	5.28e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOA1—coronary artery disease	3.37e-06	5.24e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.36e-06	5.24e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—coronary artery disease	3.36e-06	5.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	3.34e-06	5.19e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAK2—coronary artery disease	3.34e-06	5.19e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.27e-06	5.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—DCN—coronary artery disease	3.27e-06	5.08e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—coronary artery disease	3.26e-06	5.07e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—coronary artery disease	3.23e-06	5.03e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.2e-06	4.99e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.18e-06	4.94e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.17e-06	4.94e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	3.16e-06	4.92e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.16e-06	4.92e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAT—coronary artery disease	3.12e-06	4.85e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LIPC—coronary artery disease	3.1e-06	4.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HBA1—coronary artery disease	3.1e-06	4.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.1e-06	4.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.1e-06	4.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOC3—coronary artery disease	3.08e-06	4.79e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	3.06e-06	4.77e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LDLR—coronary artery disease	3.06e-06	4.76e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	3.04e-06	4.74e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOB—coronary artery disease	3.03e-06	4.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.02e-06	4.7e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.02e-06	4.7e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	3e-06	4.67e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCLC—coronary artery disease	2.99e-06	4.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CETP—coronary artery disease	2.99e-06	4.65e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—coronary artery disease	2.97e-06	4.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDC1—coronary artery disease	2.95e-06	4.6e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.94e-06	4.58e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.94e-06	4.58e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—coronary artery disease	2.93e-06	4.55e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	2.93e-06	4.55e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—coronary artery disease	2.91e-06	4.54e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—coronary artery disease	2.89e-06	4.51e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPL—coronary artery disease	2.89e-06	4.5e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—coronary artery disease	2.84e-06	4.41e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—coronary artery disease	2.82e-06	4.39e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.79e-06	4.34e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.79e-06	4.34e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—coronary artery disease	2.75e-06	4.29e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CD36—coronary artery disease	2.74e-06	4.27e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CTGF—coronary artery disease	2.73e-06	4.24e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.71e-06	4.22e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.7e-06	4.2e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GOT2—coronary artery disease	2.7e-06	4.2e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	2.68e-06	4.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	2.67e-06	4.16e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—coronary artery disease	2.67e-06	4.15e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	2.63e-06	4.1e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	2.61e-06	4.06e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.6e-06	4.05e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—coronary artery disease	2.55e-06	3.97e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.48e-06	3.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	2.47e-06	3.85e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AGT—coronary artery disease	2.47e-06	3.85e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—coronary artery disease	2.42e-06	3.77e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.41e-06	3.75e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA1—coronary artery disease	2.39e-06	3.73e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.33e-06	3.63e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GGT1—coronary artery disease	2.33e-06	3.63e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GOT1—coronary artery disease	2.33e-06	3.63e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—coronary artery disease	2.31e-06	3.59e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	2.28e-06	3.56e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	2.27e-06	3.53e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	2.23e-06	3.46e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—coronary artery disease	2.13e-06	3.31e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—coronary artery disease	2.11e-06	3.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.09e-06	3.26e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—coronary artery disease	2.08e-06	3.24e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.07e-06	3.23e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.07e-06	3.22e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAT—coronary artery disease	2.04e-06	3.17e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—coronary artery disease	2.02e-06	3.15e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.99e-06	3.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOB—coronary artery disease	1.98e-06	3.08e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.93e-06	3.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.92e-06	3e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—coronary artery disease	1.9e-06	2.95e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPL—coronary artery disease	1.89e-06	2.94e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—coronary artery disease	1.87e-06	2.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.84e-06	2.87e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—coronary artery disease	1.81e-06	2.82e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CD36—coronary artery disease	1.79e-06	2.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.77e-06	2.76e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—coronary artery disease	1.71e-06	2.66e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.7e-06	2.65e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.66e-06	2.58e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—coronary artery disease	1.62e-06	2.53e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AGT—coronary artery disease	1.62e-06	2.52e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—coronary artery disease	1.58e-06	2.46e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—coronary artery disease	1.58e-06	2.46e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA1—coronary artery disease	1.57e-06	2.44e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.44e-06	2.24e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—coronary artery disease	1.38e-06	2.15e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—coronary artery disease	1.36e-06	2.12e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—coronary artery disease	1.24e-06	1.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—coronary artery disease	1.19e-06	1.85e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—coronary artery disease	1.17e-06	1.83e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.08e-06	1.69e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.02e-06	1.59e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—coronary artery disease	8.34e-07	1.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.67e-07	1.04e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—coronary artery disease	5.45e-07	8.49e-06	CbGpPWpGaD
